Enter Title

CDC Webinars on Meaningful Use and HL7 Clinical Document Architecture (CDA)

Meaningful Use

As part of Stage 2 Meaningful Use (MU), Eligible Professionals (EPs) can choose “Cancer Reporting” as a public health reporting objective to receive incentives from the Centers for Medicare and Medicaid (CMS) to implement certified electronic health record (EHR) systems to report cancer data to state cancer registries. In MU Modified Stage 2, EPs can continue to report cancer cases, but it is now as part of the Specialized Registry Reporting measure. In MU Stage 3, EPs can report cancer cases as part of the Public Health Registry Reporting measure.

The Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries National Program of Cancer Registries (NPCR) will host various webinars to provide the cancer community with information, guidance, and technical assistance with implementation of Cancer Reporting in Meaningful Use (MU). Recordings and associated documents from past webinars can be found below.

Physician Reporting 

CDC Town Hall Meeting: Registry Discussion for Physician Reporting Processes - October 19, 2016

NPCR hosted a town hall meeting in which three states, North Carolina, New Jersey, and Iowa, shared their processes related to Physician Reporting of cancer cases. The discussion included their experiences with validation, eMaRC Plus, vendor and provider communication, lessons learned and challenges. The slides and recordings are available for your reference.

HL7 Clinical Document Architecture (CDA)

Clinical Document Architecture (CDA) Training Part 1 - July 23, 2015

NPCR is providing a two part training on HL7 Clinical Document Architecture (CDA). The first session, held on Thursday, July 23, 2015, provided a foundation on how CDA works, with a focus on understanding concepts such as templates, optionality, Object Identifiers (OIDs), value sets, code systems, document structure, and implementation guides. The second session (date TBD) will focus on how to read and find information in a cancer CDA document, and will include walking participants through how to validate and analyze actual cancer CDA reports received from EHRs. The slides and recordings are available for your reference.

Guidance Documents

CDC Workgroup Meetings 

  • NPCR-AERRO ePath WG Meeting – Second Thursdays from 3:00 pm to 4:00 pm ET
  • Physician Reporting Workgroup – First and Third Mondays from 3:00 pm to 4:30 pm ET
  • CDC-NPCR Meaningful Use Workgroup – Second Wednesdays from 3:00 pm to 4:00 pm ET
Please contact Lindsay Ryan at viu3@cdc.gov to receive an invite to these meetings.

Other Meetings and Resources